スギモト ケン
Ken Sugimoto
杉本 研 所属 川崎医科大学 医学部 臨床医学 総合老年医学 職種 教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Disease-associated polymorphisms in 9p21 are not associated with extreme longevity. |
掲載誌名 | 正式名:Geriatrics & gerontology international 略 称:Geriatr Gerontol Int ISSNコード:14470594/14470594 |
掲載区分 | 国外 |
巻・号・頁 | 15(6),pp.797-803 |
著者・共著者 | Congrains Ada, Kamide Kei, Hirose Nobuyoshi, Arai Yasumichi, Oguro Ryousuke, Nakama Chikako, Imaizumi Yuki, Kawai Tatsuo, Kusunoki Hiroshi, Yamamoto Hiroko, Onishi-Takeya Miyuki, Takeya Yasushi, Yamamoto Koichi, Sugimoto Ken, Akasaka Hiroshi, Saitoh Shigeyuki, Miura Tetsuji, Awata Nobuhisa, Kato Norihiro, Katsuya Tomohiro, Ikebe Kazunori, Gondo Yasuyuki, Rakugi Hiromi |
発行年月 | 2015/06 |
概要 | AIM:The 9p21 region has been pointed out by the genome-wide association studies as a hot spot for disease-associated variants. Most of the diseases linked with the locus are aging-related conditions, such us cardiovascular disease, diabetes and cancer. Centenarians are known to present a reduced risk and delayed onset for these conditions. Here, we aimed to assess if the 9p21 variants contribute to this protection by possibly altering basic aging mechanisms.METHODS:We genotyped 15 tag single-nucleotide polymorphisms (SNP) along the CDKN2A/B/ANRIL locus in 1505 individuals. The participants were divided in three groups: centenarians, septuagenarians and young controls. Centenarians were 593 participants (age range 100-116 years, mean 105.9 years), septuagenarians were 434 volunteers aged between 69 and 71 years (mean 70.1 ± 0.9 years) and the 478 young controls were under the age of 50 years (range 14-50 years, mean 41.8 years). We genotyped the SNP rs1333049 in an additional sample of 231 coronary artery disease patients to confirm the 9p21 association.RESULTS:The leading coronary artery disease-associated SNP rs1333049 was associated with coronary artery disease; however, none of the 9p21 SNP evaluated in the present study were associated with extreme longevity.CONCLUSIONS:Our findings suggest that the 9p21 disease-associated polymorphisms do not contribute to the life-long protection from cardiovascular and other age-related diseases observed in centenarians. It is likely that this protection is mediated by mechanisms different from the ones underlying the 9p21 association. |
DOI | 10.1111/ggi.12346 |
PMID | 25257646 |